Optiver Holding B.V. Fate Therapeutics Inc Transaction History
Optiver Holding B.V.
- $3.01 Billion
- Q4 2024
A detailed history of Optiver Holding B.V. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Optiver Holding B.V. holds 570 shares of FATE stock, worth $621. This represents 0.0% of its overall portfolio holdings.
Number of Shares
570Holding current value
$621% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding FATE
# of Institutions
167Shares Held
101MCall Options Held
41.3KPut Options Held
15.9K-
Redmile Group, LLC San Francisco, CA12.9MShares$14 Million1.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$11.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$11 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.84MShares$5.28 Million0.16% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.38MShares$4.78 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $106M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...